Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

58

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

58 results for “Agonist antibody”

Learn how ShareScore rates datasets ↗
dryad32/100

A novel TNFR2 agonist antibody expands highly potent regulatory T cells

<p>Regulatory T cells (T<sub>reg</sub> cells) restrict immune system activity, such as in response to self-antigens, and are switched on by tumor necrosis factor receptor 2 (TNFR2). Therapeutic activation of TNFR2, thereby expanding T<sub>reg</sub> cells and suppressing immune activity, may be beneficial to patients with various inflammatory diseases. Here, we characterized a new human TNFR2-directed antibody agonist isolated from mice. We found that the antibody agonist expanded the number of T<sub>reg</sub> cells within cultures of primary human CD4<sup>+</sup> T cells from healthy donors and patients with type 1 diabetes or Sézary syndrome. These T<sub>reg</sub> cells had increased metabolic gene expression and intracellular itaconate concentrations, characteristics associated with maximally suppressive, anti-inflammatory T<sub>reg</sub> cells. Furthermore, antibody-expanded T<sub>reg</sub> cells repressed the activity of primary human CD8<sup>+</sup> effector T cells (T<sub>eff</sub> cells). Epitope mapping suggested that the antibody bound to TNFR2 through a natural cross-linking surface and that T<sub>reg</sub> cell expansion was independent of the antibody Fc region. In addition, T<sub>reg</sub> cell expansion was not increased by adding either supplemental TNF ligand or a cross-linking reagent, suggesting that the antibody agonist by itself can elicit maximal activity, a notion that was confirmed by increased secretion of soluble TNFR2. Pending in vivo tests, these features indicate that this TNFR2 antibody agonist has the potential to safely and effectively treat various inflammatory disorders.</p>

opencc-zeroNov 2020View details →
ClinicalTrials.gov32/100

TLR9 Agonist SD-101, Anti-OX40 Antibody BMS 986178, and Radiation Therapy in Treating Patients With Low-Grade B-Cell Non-Hodgkin Lymphomas

ClinicalTrials.gov study NCT03410901. IPD Sharing: NO. Countries: 1. Publications: 2.

closedIPD-NOFeb 2026View details →
dryad32/100

A novel TNFR2 agonist antibody expands highly potent regulatory T cells

Open the record for dataset details and reuse information.

publicNov 2020View details →
ClinicalTrials.gov28/100

Study of REGN4461, a Leptin Receptor Agonist Antibody, in Patients With Generalized Lipodystrophy

ClinicalTrials.gov study NCT04159415. IPD Sharing: YES. Countries: 4. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov28/100

FLT3 Ligand, CD40 Agonist Antibody, and Stereotactic Radiotherapy

ClinicalTrials.gov study NCT04491084. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

4-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients With Advanced HER2-Positive Breast Cancer

ClinicalTrials.gov study NCT03364348. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

A Study to Examine the Effects of the Leptin Receptor (LEPR) Agonist Antibody REGN4461 in Adult Patients With Familial Partial Lipodystrophy (FPLD)

ClinicalTrials.gov study NCT05088460. IPD Sharing: YES. Countries: 4. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov28/100

CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab

ClinicalTrials.gov study NCT03123783. IPD Sharing: NO. Countries: 2. Publications: 0.

closedIPD-NOFeb 2026View details →
geo24/100

SIRPa agonist antibody treatment ameliorates experimental arthritis and colitis

GEO Series GSE236928. Homo sapiens; Mus musculus. 144 samples. Type: Expression profiling by high throughput sequencing; Expression profiling by array.

openGEO-OpenAug 2023View details →
geo24/100

Rational derivation of midbrain dopamine neuron progenitors from hPSCs using a selective FZD5 antibody agonist [scRNA-Seq]

GEO Series GSE241042. Homo sapiens. 4 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenFeb 2024View details →
geo24/100

Rational derivation of midbrain dopamine neuron progenitors from hPSCs using a selective FZD5 antibody agonist [RNA-Seq]

GEO Series GSE241041. Homo sapiens. 8 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenFeb 2024View details →
geo24/100

An agonistic anti-CD137 antibody promotes inflammatory signatures in immune cells that disrupt germinal center formation and T cell-dependent antibody responses

GEO Series GSE141111. Mus musculus. 5 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenDec 2019View details →
geo24/100

Transcriptional Responses to TREM2 Agonist Antibody Treatment in Cynomologus Monkey Brain [single nuclei RNA sequencing]

GEO Series GSE241190. Macaca fascicularis. 16 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenDec 2024View details →
geo24/100

Expression data of human Tregs treated with TNFR2 agonist antibody

GEO Series GSE185145. Homo sapiens. 5 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenJan 2022View details →
geo24/100

An agonistic anti-CD137 antibody promotes inflammatory signatures in immune cells that disrupt germinal center formation and T cell-dependent antibody responses II

GEO Series GSE141117. Mus musculus. 3 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenDec 2019View details →
geo24/100

ABBV-319: A First-In-Class CD19-targeting Glucocorticoid Receptor Modulator (GRM) Agonist Antibody-Drug Conjugate (ADC) for the Treatment of B-cell Malignancies [RNA-seq]

GEO Series GSE249023. Homo sapiens. 12 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenDec 2023View details →
geo24/100

Rational derivation of midbrain dopamine neuron progenitors from hPSCs using a selective FZD5 antibody agonist

GEO Series GSE241043. Homo sapiens. 12 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenFeb 2024View details →
geo24/100

Fc-optimized CD40 Agonistic Antibody Induces Tertiary Lymphoid Structures and Systemic Antitumor Immunity in Metastatic Cancer Patients [Human]

GEO Series GSE298047. Homo sapiens. 48 samples. Type: Other; Expression profiling by high throughput sequencing.

openGEO-OpenMay 2025View details →
geo24/100

Single-cell RNA-seq data of human Tregs treated with TNFR2 agonist antibody

GEO Series GSE185144. Homo sapiens. 5 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenJan 2022View details →
geo24/100

Expression data of iPS microglia treated with TREM2 agonist antibody

GEO Series GSE159333. Homo sapiens. 9 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenSep 2021View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record